Roumane, AhlimaMcilroy, George DBalci, ArdaHan, WeipingDelibegović, MirelaBaldassarre, MassimilianoNewsholme, PhilipRochford, Justin J2021-02-252021-02-252021-01-23Roumane, A, Mcilroy, G D, Balci, A, Han, W, Delibegović, M, Baldassarre, M, Newsholme, P & Rochford, J J 2021, 'Bscl2 Deficiency Does Not Directly Impair the Innate Immune Response in a Murine Model of Generalized Lipodystrophy', Journal of Clinical Medicine, vol. 10, no. 3, 441. https://doi.org/10.3390/jcm100304412077-0383PubMedCentral: PMC7865406ORCID: /0000-0002-2498-4767/work/90173063ORCID: /0000-0002-5020-4939/work/90174357ORCID: /0000-0003-4230-4355/work/102133119https://hdl.handle.net/2164/15929Funding: Work was supported by Diabetes UK (JJR;18/0005884, MD;17/0005621) the Medical Research Council (JJR; MR/L002620/1, MC/PC/15077), the British Heart Foundation (MD; PG/14/43/30889), The Agency for Science, Technology and Research, Singapore (A*STAR) (WH), The Wellcome Trust (ISSF Funding to GDM) and the European Union’s Horizon 2020 ERC consolidator award (MB:2016-726152-TYPHI).101151608engBSCL2seipin; congenital generalized lipodystrophyimmunitymacrophagesR MedicineMedical Research Council (MRC)MR/L002620/1MC/PC/15077British Heart FoundationPG/14/43/30889European Research Council2016-726152-TYPHIWellcome Trust204815/Z/16/ZRJournal article10.3390/jcm10030441https://www.mdpi.com/2077-0383/10/3/441/s1103